Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Q4 Revenues Rise 8 Percent, Sees a Profit

NEW YORK (GenomeWeb News) – Danish miRNA firm Exiqon today reported an 8 percent jump in fourth-quarter revenue, reaching profitability.

For the three months ended Dec. 31, 2011, revenues came in at DKK 30.1 million ($5.4 million), up from DKK27.8 million a year ago.

Total operating expenses was reduced to DKK10.6 million from DDD12.4 million, and during the quarter Exiqon made a profit of DKK825 million, or DKK.02 per share, compared to a net loss of DKK8.9million a year ago.

Full-year revenues came in at DKK111.5 million, up 19 percent from DKK93.5 million in 2010. The company said that Life Sciences product sales rose 36 percent organically paced by Exiqon's proprietary miRCURY LNA Universal RT-PCR platform for miRNA research.

Total operating expenses for 2011 was DKK49.3 million, a 9 percent increase from DKK45.4 million a year ago.

Exiqon posted a net loss of DKK24.9 million, or DKK.73 per share, compared to a net loss of DKK43.5 million, or DKK1.32, in 2010.

CEO Lars Kongsbak said in a statement that the firm saw continued improvement in all key financial figures during 2011 and reached an "important milestone" of profitability in the fourth quarter.

"The goal for 2012 is a positive [earnings before interest and taxes], driven by a continued strong growth in our core business of life science product sales," he said.

He added that during the year the company plans to launch a "comprehensive portfolio" of new diagnostic products for miRNA analysis and expects to deliver its first validated biomarker profile for the early detection of colorectal cancer.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.